Adam Cutler Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in...

Talkiatry appoints Jared Camins as Chief Technology Officer Closely-held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed...

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

Doug Kleinberg Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma.  Mr...

John Boris John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested...

Jonathan Talamo Closely-held Ripple Therapeutics named Jonathan Talamo, M.D., an internationally known ophthalmologist, innovator and consultant to the industry with more than 25 years of experience in healthcare, to...

X-ray manufacturer, KA Imaging, appointed Dr. Philip Templeton, M.D., to the newly created position of chief medical officer (CMO). A board certified radiologist, Dr. Templeton brings over 38 years of academic and...

Nurx, a telehealth platform providing convenient and affordable care for female health needs, appointed Dr. Jennifer Peña, M.D., as chief medical officer to help Nurx build on a record year of growth and begin treating...

Jim Lilly Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

Justin Zelin BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology...

Joseph Walewicz Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining...